Kisspeptin Expression Across the Menstrual Cycle: Regulation by Gonadotropins, Steroids, and Metabolic Signals
Kisspeptin expression varies dynamically across the menstrual cycle in a tissue-specific and phase-dependent manner, with distinct regulatory mechanisms in the hypothalamus and ovary. In the ovary, *Kiss1* mRNA levels peak during the preovulatory phase, coinciding with the LH surge and likely driven by gonadotropin action itself, suggesting a feedback loop where gonadotropins regulate ovarian kisspeptin expression [1]. In contrast, hypothalamic kisspeptin expression is primarily governed by sex steroids: in the arcuate nucleus (Arc), it is suppressed by estradiol and testosterone (negative feedback), while in the anteroventral periventricular nucleus (AVPV) or rostral periventricular area of the third ventricle (RP3V) in primates, it is enhanced by high estradiol (positive feedback), enabling the preovulatory GnRH/LH surge [3]. These patterns are further modulated by metabolic signals such as leptin and intrinsic regulatory circuits involving neurokinin B (NKB) and dynorphin within KNDy neurons [10,13].
What the AI assistants say
AI assistants emphasize kisspeptin’s central role in regulating the hypothalamic-pituitary-gonadal (HPG) axis through pulsatile GnRH release, primarily mediated by two hypothalamic populations: KNDy neurons in the arcuate nucleus (ARC), which regulate GnRH pulse frequency via negative feedback by estradiol, and AVPV/RP3V neurons, which mediate positive feedback to trigger the preovulatory LH surge [1]. They describe the early follicular phase as characterized by low estradiol, disinhibiting ARC kisspeptin neurons and supporting moderate GnRH pulse frequency, while the late follicular phase features rising estradiol that suppresses ARC kisspeptin but strongly activates AVPV/RP3V kisspeptin, culminating in the LH surge [1]. These models are consistent with animal studies showing that gonadectomy increases ARC kisspeptin expression, which is reversed by estradiol replacement, and that AVPV kisspeptin expression increases with steroid exposure [3]. The AI assistants also note that kisspeptin’s pulsatility is regulated by the KNDy neuron network, where NKB excites and dynorphin inhibits kisspeptin release, forming a self-regulatory oscillator [13]. However, they largely omit the ovarian expression of kisspeptin and its regulation by gonadotropins, focusing almost exclusively on hypothalamic control.
What the research actually shows
While the hypothalamic regulation of kisspeptin is well established, emerging evidence reveals that kisspeptin is also expressed in peripheral reproductive tissues, particularly the ovary, where its expression pattern diverges significantly from the hypothalamus. In rats, *Kiss1* mRNA levels in the ovary peak during the preovulatory phase, coinciding with the LH surge and suggesting a role in ovulation [1]. This expression is not merely a passive response to steroid levels but appears to be actively regulated by gonadotropins themselves. For instance, in a rat model of ovulatory dysfunction induced by prostaglandin synthesis inhibition, ovarian *Kiss1* mRNA levels were markedly suppressed during the ovulatory period, correlating with disrupted ovulation [1]. This indicates that intact gonadotropin signaling—particularly LH—is necessary for maintaining normal ovarian kisspeptin expression, positioning kisspeptin as a downstream effector of gonadotropin action in the ovary.
Immunohistochemical studies confirm kisspeptin expression in multiple ovarian compartments, including theca cells, corpora lutea, and interstitial glands, in both rat and primate species [1]. This widespread localization suggests that kisspeptin may act locally via paracrine or autocrine mechanisms to influence follicular development, steroidogenesis, or luteal function. The cyclical nature of ovarian kisspeptin expression, peaking just before ovulation, implies a direct involvement in the final maturation and release of the oocyte. This contrasts sharply with the hypothalamic pattern, where expression is driven by steroid feedback rather than gonadotropin feedback.
Within the hypothalamus, kisspeptin expression is regulated by sex steroids in a region-specific manner. In the arcuate nucleus, *Kiss1* expression increases after gonadectomy (i.e., in the absence of sex steroids) and is fully suppressed by estradiol or testosterone replacement, demonstrating negative feedback [3]. In contrast, in the AVPV/RP3V, *Kiss1* mRNA levels decrease after gonadectomy and increase with steroid replacement, reflecting positive feedback [3]. This dichotomy is critical for the generation of the preovulatory LH surge: the AVPV acts as the “surge generator,” integrating high estradiol levels to trigger massive GnRH release [3]. This sexually dimorphic nucleus contains significantly more kisspeptin-expressing neurons in females, underscoring its role in female reproductive cyclicity.
Early-life estrogen exposure further shapes hypothalamic kisspeptin expression. Neonatal estrogenization leads to decreased *Kiss1* expression in the hypothalamus, which may contribute to long-term reproductive dysfunction such as impaired fertility or altered gonadotropin dynamics [14]. This highlights the developmental programming of the kisspeptin system, which is sensitive to estrogenic signals during critical periods and can be permanently altered by early hormonal exposure.
Metabolic signals also influence kisspeptin expression. In leptin-deficient *ob/ob* mice, *Kiss1* mRNA levels in the arcuate nucleus are reduced, and this reduction can be partially reversed by leptin administration [10]. This suggests that metabolic status, particularly energy availability, modulates kisspeptin expression and may link nutritional status to reproductive function. However, while deletion of leptin receptors specifically in kisspeptin neurons does not affect puberty or fertility, deletion in GABAergic neurons leads to hypogonadotropic hypogonadism and reduced kisspeptin expression in both Arc and AVPV [10]. This indicates that metabolic regulation of kisspeptin is likely indirect, mediated through other neuronal populations rather than direct action on kisspeptin neurons themselves.
Finally, the pulsatile secretion of kisspeptin—essential for maintaining GnRH pulse frequency—is governed by intrinsic hypothalamic circuitry. KNDy neurons in the Arc coexpress kisspeptin, NKB, and dynorphin, forming a self-regulatory network where NKB stimulates kisspeptin release and dynorphin inhibits it [13]. This balance generates episodic kisspeptin pulses that drive pulsatile GnRH secretion. Mutations in *TAC3* (encoding NKB) or *TACR3* (its receptor) cause hypogonadotropic hypogonadism, similar to mutations in *GPR54*, underscoring the importance of this regulatory circuit [14].
Where the AI consensus and the research diverge
The AI assistants largely overlook the ovarian expression of kisspeptin and its regulation by gonadotropins, focusing almost exclusively on hypothalamic regulation via steroid feedback. While they correctly describe the opposing roles of ARC and AVPV kisspeptin neurons in negative and positive feedback, they fail to acknowledge that ovarian kisspeptin expression peaks during the preovulatory phase and is regulated by the LH surge itself [1]. This represents a significant divergence: the research shows that kisspeptin is not only a central regulator but also a peripheral effector in the ovary, where it may play a direct role in ovulation. The AI models, by contrast, present a unidirectional hypothalamic-centric view, missing the feedback loop between gonadotropins and ovarian kisspeptin. This omission limits their understanding of kisspeptin’s full physiological role across the menstrual cycle.
Bottom line: Kisspeptin expression varies across the menstrual cycle in both the ovary and hypothalamus, with ovarian levels peaking preovulatorily and being regulated by gonadotropins, while hypothalamic expression is controlled by sex steroids (negative feedback in Arc, positive feedback in AVPV), metabolic signals (e.g., leptin), and intrinsic KNDy neuron circuits involving NKB and dynorphin [1,3,10,13,14].
References
- Endocrinology_ Adult and Pediatric
- Handbook of Biologically Active Peptides
- Williams Textbook of Endocrinology
Continue your research
Part of our Kisspeptin: Mechanisms & How It Works guide.
- What is the molecular mechanism by which kisspeptin activates gonadotropin-releasing hormone (GnRH) neurons, and how does this regulate the hypothalamic-pituitary-gonadal (HPG) axis?
- How do kisspeptin receptor (KISS1R) signaling pathways modulate neuronal excitability in the arcuate nucleus and anteroventral periventricular nucleus?
- What role does kisspeptin play in the pulsatile release of GnRH, and how does this influence gonadotropin secretion and reproductive function?
Related topics:
- What are the optimal dosing regimens for kisspeptin in clinical trials for fertility induction, and how do they vary by route of administration?
- How does kisspeptin affect neuroendocrine regulation of mood, stress response, and anxiety through interactions with the HPA axis?
- What evidence exists for kisspeptin’s role in modulating cognitive function, memory, and neuroplasticity in animal models?